“about 600 Americans under the age of 18 have died of COVID-19 during the pandemic. A new study from the Centers for Disease Control and Prevention (CDC) took a closer look at young people who were hospitalized for COVID-19 in July and August, while the delta variant wave took hold, and largely found that healthy young people continue to mostly evade the worst of COVID-19.
The study found that most young people who suffer severe COVID-19 outcomes had underlying health conditions. The most common, especially for teenagers, was obesity.”
“Electronic cigarettes, which deliver nicotine without tobacco or combustion, are the most important harm-reducing alternative to smoking ever developed, one that could prevent millions of premature deaths in the U.S. alone. Yet bureaucrats and politicians seem determined to negate that historic opportunity through regulations and taxes that threaten to cripple the industry.”
“Survey data indicate that the vast majority of teenagers who vape regularly are current or former smokers. That means the FDA’s fear that ENDS are causing an “epidemic” of adolescent nicotine addiction is overblown—especially since vaping by teenagers dropped substantially in 2019 and 2020, a development the agency prefers to ignore.”
” In an August American Journal of Public Health article, 15 prominent tobacco researchers warned that “policies intended to reduce adolescent vaping,” including flavor bans, “may also reduce adult smokers’ use of e-cigarettes in quit attempts.” They emphasized that “the potential lifesaving benefits of e-cigarettes for adult smokers deserve attention equal to the risks to youths.”
That article summarized “a growing body of evidence” that “vaping can foster smoking cessation.” Yet Rep. Raja Krishnamoorthi (D–Ill.), who wrote a bill he called the END ENDS Act, insists “there’s simply no evidence that vapes help [smokers] quit.” He also claims to believe “adults can do what they want,” which is likewise demonstrably false given the severe restrictions he favors.”
“when Ben Carson made a bid to become the GOP’s first African American presidential nominee. Support for Carson was positively correlated with the belief that Black Americans have too much influence on U.S. politics”
“whites who thought African Americans have “far too much” influence preferred Carson to Clinton by 45 points.
Again, much of that relationship is down to partisanship — Republicans are more likely to hold prejudiced views and also more likely to support a Republican candidate. But that’s the point: For many white GOP voters, anti-Black views don’t seem to get in the way of supporting a Black Republican.”
“Carson received more favorable evaluations among the sizable minority (40 percent) of overtly prejudiced whites who agreed with the racist stereotype that “most African Americans are more violent than most whites.” This group rated Carson significantly more favorably on a 0-100 scale than the white moderate Republican presidential candidate, Jeb Bush (52 to 39, respectively). Then-candidate Donald Trump was the only politician in the survey who was rated higher than Carson among overtly prejudiced whites.”
“The sharp negative relationship between support for Obama and the endorsement of anti-Black stereotypes is consistent with several studies showing that prejudice was an unusually strong predictor of opposition to Obama from the 2008 election through the end of his presidency. These patterns also fit well with other political science research showing that racially prejudiced whites tend to be more opposed to Black Democrats than to white Democrats.”
“Given the racialized nature of the two-party system in the United States, most Black political candidates are Democrats who embrace liberal positions on issues of race and justice. When asked whether they would support such a candidate, research shows that racially prejudiced white voters worry that these candidates will represent the interests of Black Americans, both because of a shared African American identity and because Democrats are perceived as the party more supportive of Black interests. So, it makes sense that racially resentful white Americans oppose candidates like Obama, as his racial identity and partisanship signaled to voters that he was more supportive of Black interests than prior presidents.
Put another way: Racially prejudiced white voters are not opposed to Black candidates simply because they are Black, but because they believe that most Black candidates will fight for “those people” and not “people like us.”
Black Republicans, on the other hand, are perceived differently by racially prejudiced white Americans. Their embrace of the Republican Party and its conservative ideology help assure racially prejudiced whites that, unlike Black Democrats, they are not in the business of carrying water for their own racial group.”
“voting for Black Republicans may also be especially appealing to racially prejudiced whites because it assuages concerns of being seen as racist by enabling them to say, in essence, “I can’t be racist! I voted for a Black candidate!” Psychologists call this “moral credentialing,” and there’s even some evidence that voters who expressed support for Obama shortly after the 2008 election felt more justified in favoring white Americans over Black Americans. Electing a Black Republican like Sears, who railed against critical race theory during the run-up to the election and supports voting restrictions that adversely affect racial minorities, is similarly used as a symbolic shield by the entire party from inevitable charges of championing racist policies. As we mentioned earlier, conservative media outlets and politicians are already weaponizing her victory against anyone who would dare suggest so.”
“Marijuana is nowhere as dangerous as alcohol. You can quite literally drink yourself to death; the same doesn’t apply to marijuana. So it’s almost certain that legalizing marijuana the same way won’t lead to all the same bad outcomes.
Still, there are some risks. A thorough review of the research, by the National Academies of Sciences, Engineering, and Medicine, found that marijuana poses a variety of possible downsides, which can include a higher risk of respiratory problems (if smoked), an increased risk of developing schizophrenia and other psychoses, an increased likelihood of car crashes, a general decrease in social achievement, and, potentially, some harm to fetuses in the womb.
There’s also the real risk of addiction and overuse. As Stanford’s Keith Humphreys put it to the Atlantic, “In large national surveys, about one in 10 people who smoke [marijuana] say they have a lot of problems. They say things like, ‘I have trouble quitting. I think a lot about quitting and I can’t do it. I smoked more than I intended to. I neglect responsibilities.’ … People will say, ‘Oh, that’s just you fuddy-duddy doctors.’ Actually, no. It’s millions of people who use the drug who say that it causes problems.”
None of that is to make the argument for prohibition, which produces its own problems”
“An obvious question is: If the standard commercial model works for alcohol, why can’t it work for a newly legal drug like cannabis, too?
But this model doesn’t work well for alcohol. The nation’s second-most popular drug (after caffeine) is linked to nearly 100,000 deaths a year in the US — about the same as all overdose deaths, and more than the combined death tolls of car crashes and murders.
A different model could help. Previous research, for example, found that states that maintained a government-operated monopoly for alcohol kept prices higher, reduced access to youth, and cut overall levels of use”
“Younger, less-well-educated workers have been especially harmed by recent state-level minimum wage hikes, according to a study issued today by the National Bureau of Economic Research. The paper was written by economists Jeffrey Clemens of the University of California, San Diego, and Michael R. Strain of the American Enterprise Institute.”
“They found that “over the short and medium run, relatively large increases in minimum wages have reduced employment rates among individuals with low levels of experience and education by just over 2.5 percentage points.” By contrast, smaller increases, or ones resulting from indexing inflation to wages, have effects that are “variable and centered on zero.”
The data also offers “evidence that the medium-run effects of large minimum wage changes are larger and more negative than their short-run effects,” so we will often need time to unfold before we see those bad employment effects blossom.”
“So what do researchers know about the effectiveness of ivermectin, approved for human use but best known as a horse deworming medicine, in treating COVID-19? At the beginning of the pandemic, scientists around the globe began testing thousands of existing medications in test tubes to see if they could be repurposed to fight against the novel coronavirus. In very preliminary research, researchers found that ivermectin significantly inhibited COVID-19 coronaviruses in cell cultures.
Encouraged by these petri dish findings, some desperate clinicians began administering ivermectin to their COVID-19 patients. The result was a number of hopeful observational studies by clinicians reporting that ivermectin appeared to be effective—in some cases, highly effective—in preventing COVID deaths. Observational studies are notoriously subject to researcher biases and confounders that can mislead clinicians into thinking an intervention works when actually a third factor is responsible.
Nevertheless, a prominent group of American physicians calling themselves the Front Line COVID-19 Critical Care Alliance (FLCCC) combined these preliminary observational and epidemiological studies into a November 13, 2020, preprint meta-analysis asserting that ivermectin “has highly potent real-world, anti-viral, and anti-inflammatory properties against SARS-CoV-2 and COVID-19.” Among other findings, the FLCCC pointed to reports that widespread distribution of ivermectin in Peru had correlated with steep declines in COVID-19 cases and mortality there. According to the group, cases and deaths began to rise dramatically in the same country after the government ceased distributing the drug.”
“research on ivermectin’s efficacy in treating COVID-19 has been ongoing. Has this subsequent research validated Kory’s claim that ivermectin is a miracle drug against COVID-19? It’s complicated, but the answer is largely no.
First: Those dramatic Peruvian results are highly confounded. The steep rise in COVID-19 cases and deaths in that country can most likely be blamed on the breakout of the highly infectious lambda variant rather than to a halt in ivermectin distribution. Meanwhile, the newly reported results of a highly anticipated randomized controlled study of ivermectin in next door Brazil finds that the medicine had “no effect whatsoever” on the disease.
A lot of the hope that ivermectin would be a COVID-19 silver bullet arose from the findings of various meta-analyses, including the one conducted by the FLCCC, that combined the results of various observational studies and small randomized controlled trials. One of the more prominent recent ones was posted as a preprint in May by a team of British public health researchers led by the Newcastle University statistician Andrew Bryant. But other scientists have faulted that study for significant methodological failures.
Also, though it’s not the preprint’s researchers fault, one of the most important studies bolstering their conclusion has been withdrawn because its results appear to be fraudulent. Once the data from that study are removed, the Bryant meta-analysis finds essentially no efficacy for treating COVID-19 with ivermectin.
On July 28, 2021, the authors of a more painstaking meta-analysis of ivermectin COVID-19 treatment studies, published by the Cochrane Library, concluded:
“Based on the current very low‐ to low-certainty evidence, we are uncertain about the efficacy and safety of ivermectin used to treat or prevent COVID‐19. The completed studies are small and few are considered high quality. Several studies are underway that may produce clearer answers in review updates. Overall, the reliable evidence available does not support the use of ivermectin for treatment or prevention of COVID‐19 outside of well‐designed randomized trials.”
The FLCCC folks are surely sincere, but the best evidence suggests that they are sincerely wrong. The bottom line is that while ivermectin might have some marginal efficacy, it is certainly not a “miracle drug” when it comes to treating COVID-19.”
“his flat, categorical statements about cloth masks are stronger than the scientific literature supports, relying on a couple of cherry-picked studies with known limitations while ignoring countervailing evidence.
In a video responding to his YouTube suspension, Paul reiterates that “most of the masks that you get over the counter don’t work” and “don’t prevent infection.” He argues that “saying cloth masks work when they don’t actually risks lives,” describing it as “potentially deadly misinformation.” While N95 respirators are effective at preventing virus transmission, he says, “the other masks don’t work.”
Paul would have been on firm ground if he had said cloth masks offer less protection than N95 masks. But the claim that cloth masks “don’t work,” meaning they offer no protection at all, is inconsistent with multiple studies suggesting that they reduce the risk of infection, especially when worn by carriers but possibly also when worn by other people in their vicinity.”
“Bolstered with better data and even clearer trends, they’re no longer reluctant to point the finger back at humanity for worsening these calamities. In the latest report from the Intergovernmental Panel on Climate Change (IPCC), a team of leading researchers convened by the United Nations presented some of the most robust research that connects the dots. It shows how some greater weather extremes can be traced back to rising average temperatures, which in turn stem from emissions of greenhouse gases, mainly from countries and corporations burning fossil fuels.
“On a case-by-case basis, scientists can now quantify the contribution of human influences to the magnitude and probability of many extreme events,” according to the report.”